Should we perform subtotal hysterectomy associated with sacral colpopexy for genital prolapse to prevent the risk of endometrial cancer?
article
OA: closed
CC0
AI-generated summary
This paper investigates whether performing subtotal hysterectomy along with sacral colpopexy for genital prolapse reduces the risk of endometrial cancer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveIn a menopausal woman scheduled for curative surgery for pelvic organ prolapse (POP) by sacral colpopexy (SC), the question of concomitant hysterectomy is frequently considered by the surgeon. The risk of endometrial cancer (EC) exists in this population, and increases with age and body mass index. The French college of gynecologists and obstetricians (CNGOF) decided to issue good practice guidelines on subtotal hysterectomy (SH) for postmenopausal women scheduled for SC for POP.MethodsThe CNGOF has decided to adopt the AGREE II and GRADE systems for grading scientific evidence. Each recommendation for practice was allocated a grade, which depends on the quality of evidence (QE) (clinical practice guidelines).ResultsThe prevalence of occult endometrial cancer (EC) found on pathological analysis after SH in this context (concomitant SH associated with SC) is low (<1%) (QE: high). Few studies have assessed the value of preoperative uterine exploration. Performing SH during SC is associated with its own risks, which may diminish the potential "carcinological prevention benefit". Uterine morcellation, performed by laparoscopy or a robot-assisted procedure, is associated with a low risk (<0.6%) of dissemination of an unknown sarcoma/EC (QE: moderate) A risk of dissemination of parasitic myomas (<0.5%) is also possible (QE: moderate).ConclusionIt is not recommended to perform a subtotal hysterectomy associated with sacral colpopexy for the sole purpose of reducing the occurrence of endometrial cancer (Recommendation: STRONG [GRADE 1-]; the level of evidence was considered to be low and the risk-benefit balance was considered not to be favorable).
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (24)
- Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease via openalex
- W1986741170 via openalex
- W1995664907 via openalex
- W2039684790 via openalex
- W2066023489 via openalex
- W2108080908 via openalex
- W2142092890 via openalex
- W2312318134 via openalex
- W2335429869 via openalex
- W2379377042 via openalex
- W2437049810 via openalex
- W2713252110 via openalex
- W2783052634 via openalex
- W2790971027 via openalex
- W2795459266 via openalex
- W2921259065 via openalex
- W2924600371 via openalex
- W2939098457 via openalex
- W2945437887 via openalex
- W2964348639 via openalex
- W2972495471 via openalex
- W4324262885 via openalex
- W1924610061 via openalex
- W6676399672 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK